Literature DB >> 15038915

Molecular genetics of Alzheimer's disease.

Pau Pastor1, Alison M Goate.   

Abstract

Alzheimer disease (AD) is the most common cause of dementia. In the past decade, many advances in the understanding of the etiology of AD have been reported. Familial early onset AD is a heterogeneous disorder that can be caused by mutations in at least three different genes. Current studies are focused on identifying genetic risk factors for late onset AD. In this article, the authors will review the progress in understanding the pathogenic implications of the genes mutated in familial early onset AD and the mapping studies to identify additional genes involved in late-onset AD.

Entities:  

Mesh:

Year:  2004        PMID: 15038915     DOI: 10.1007/s11920-004-0052-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  99 in total

1.  Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I.

Authors:  U Finckh; A Alberici; M Antoniazzi; L Benussi; V Fedi; C Giannini; A Gal; R M Nitsch; G Binetti
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22.

Authors:  S Wang; C E Sun; C A Walczak; J S Ziegle; B R Kipps; L R Goldin; S R Diehl
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

3.  APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.

Authors:  C Van Broeckhoven; H Backhovens; M Cruts; J J Martin; R Crook; H Houlden; J Hardy
Journal:  Neurosci Lett       Date:  1994-03-14       Impact factor: 3.046

4.  Incidence of Alzheimer's disease in a rural community in India: the Indo-US study.

Authors:  V Chandra; R Pandav; H H Dodge; J M Johnston; S H Belle; S T DeKosky; M Ganguli
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

5.  Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease.

Authors:  S G van Duinen; E M Castaño; F Prelli; G T Bots; W Luyendijk; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats.

Authors:  J Poirier; A Baccichet; D Dea; S Gauthier
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

7.  Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

Authors:  D M Kovacs; H J Fausett; K J Page; T W Kim; R D Moir; D E Merriam; R D Hollister; O G Hallmark; R Mancini; K M Felsenstein; B T Hyman; R E Tanzi; W Wasco
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 10.  The future of genetic association studies in Alzheimer disease.

Authors:  U Finckh
Journal:  J Neural Transm (Vienna)       Date:  2003-03       Impact factor: 3.575

View more
  19 in total

Review 1.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Why does mommy forget?

Authors:  Roy Yaari; Adam S Fleisher; Anna D Burke; Helle Brand; Jan Dougherty; James D Seward; Pierre N Tariot
Journal:  Prim Care Companion CNS Disord       Date:  2011

3.  Modeling brain dynamics using computational neurogenetic approach.

Authors:  Lubica Benuskova; Nikola Kasabov
Journal:  Cogn Neurodyn       Date:  2008-09-16       Impact factor: 5.082

4.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

Review 5.  Protein phosphatases and Alzheimer's disease.

Authors:  Steven P Braithwaite; Jeffry B Stock; Paul J Lombroso; Angus C Nairn
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

6.  Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.

Authors:  Anthony L Hinrichs; Mark A Mintun; Denise Head; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Biol Psychiatry       Date:  2009-11-05       Impact factor: 13.382

7.  Insulysin cleaves the APP cytoplasmic fragment at multiple sites.

Authors:  Chitra Venugopal; Miguel A Pappolla; Kumar Sambamurti
Journal:  Neurochem Res       Date:  2007-08-15       Impact factor: 3.996

8.  Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.

Authors:  William E Klunk; Julie C Price; Chester A Mathis; Nicholas D Tsopelas; Brian J Lopresti; Scott K Ziolko; Wenzhu Bi; Jessica A Hoge; Ann D Cohen; Milos D Ikonomovic; Judith A Saxton; Beth E Snitz; Daniel A Pollen; Majaz Moonis; Carol F Lippa; Joan M Swearer; Keith A Johnson; Dorene M Rentz; Alan J Fischman; Howard J Aizenstein; Steven T DeKosky
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

9.  Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population.

Authors:  Robert P Erickson; Katherine Larson-Thomé; Lyndon Weberg; Aleksandra Szybinska; Malgorzata Mossakowska; Maria Styczynska; Maria Barcikowska; Jacek Kuznicki
Journal:  Neurosci Lett       Date:  2008-09-24       Impact factor: 3.046

Review 10.  APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.

Authors:  Leslie Crews; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Struct Funct       Date:  2009-11-29       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.